TNF and rheumatoid arthritis: Regarding the second marker of bone resorption (i.e., NTX-I), it was shown that its levels in blood serum did not differ in women with RA before and after 15 months of anti-TNF-α therapy compared to the values in healthy subjects (p = 0.385 and p = 0.403, respectively; Figure 2b).